Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment (opens ClinicalTrials.gov)
- Sponsor
- RTOG Foundation, Inc.
- Enrolment
- 130
- Started
- 2025-08-24
- Last update
- 2026-10-02
Conditions: Intracranial Meningioma
Interventions: [177Lu]Lu-DOTATATE, Standard of Care treatments